Hematologic Malignancies
Conference Coverage
CML: Preventing chemo-induced vascular toxicity
Cardiologists advise on how to ward off side effects linked to 2 TKI treatments for chronic myeloid leukemia.
News
New cancer screen, same issues: Physicians confront Galleri test
“Cancer screening is a very complicated issue. Being honest, the tests are good but are not ready yet [for wider use].”
News
Transplant vs. chemo: Similar AML survival rates
New study showed similar survival rates among AML patients treated solely with consolidation chemotherapy and those who received allogenic HCT.
News
Surviving CLL: Higher risk of other cancer DXs
A 30-year Dutch population study highlights the medical challenges facing patients with CLL, who are now living longer.
News
Despite limits, COVID vaccines protect CLL patients
A small German study found that, in patients with CLL, COVID-19 shots don’t boost B cells but they do strengthen T cells.
News
FDA approves pirtobrutinib for r/r mantle cell lymphoma
Pirtobrutinib for relapsed or refractory mantle cell lymphoma has been approved by the Food and Drug Administration.
News
Mastocytosis: Rare, underdiagnosed, potentially fatal
This often-missed myeloid neoplasm could be deadly and deserves greater attention, experts say.
News
Adding venetoclax improves ibrutinib outcomes in CLL
A small study yields sanguine news about a combination treatment, as hematologists await phase 3 results.
News
Off their pricey CML meds, many thrive
For CML patients in remission, specialists suggest trying drug omission – which often yields good outcomes and a reprieve from side effects.
News
Multiple myeloma diagnosed more via emergency care during COVID
While trying to avoid COVID-19 infection, patients ultimately diagnosed with multiple myeloma may have delayed interactions with healthcare...